Donna Ambrosino
Directeur/Membre du Conseil chez CLOVER BIOPHARMACEUTICALS, LTD.
Fortune : 6 925 $ au 30/04/2024
Profil
Donna M.
Ambrosino is a professional with a doctorate degree from Dartmouth Medical School and an undergraduate degree from Harvard University.
She is currently a Non-Executive Director at Clover Biopharmaceuticals Ltd.
since 2022.
Previously, she worked as the Chief Medical Officer at Visterra, Inc. from 2012 to 2014.
She also held the position of Associate Professor at Harvard Medical School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/04/2024 | 156 992 ( 0,01% ) | 6 925 $ | 30/04/2024 |
Postes actifs de Donna Ambrosino
| Sociétés | Poste | Début |
|---|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Directeur/Membre du Conseil | 17/06/2022 |
Anciens postes connus de Donna Ambrosino
| Sociétés | Poste | Fin |
|---|---|---|
| VISTERRA INC | Directeur Technique/Scientifique/R&D | 01/01/2014 |
| Harvard Medical School | Corporate Officer/Principal | - |
Formation de Donna Ambrosino
| Dartmouth Medical School | Doctorate Degree |
| Harvard University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Visterra, Inc.
 Visterra, Inc. Pharmaceuticals: MajorHealth Technology Visterra, Inc. Is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of antibody-based therapies for kidney diseases, and other chronic diseases. It focuses on its research technology platform, HIEROTOPE technology. The company was founded by Alan L. Crane, Kevin J. Bitterman and Ram Sasisekharan on December 20, 2007 and is headquartered in Waltham, MA. | Health Technology |
